Skip to main content
Veterinary Medicines

Bisolvon 3 mg/ml Injektionslösung für Rinder, Schweine, Hunde und Katzen

Authorised
  • Bromhexine hydrochloride

Product identification

Medicine name:
Bisolvon 3 mg/ml Injektionslösung für Rinder, Schweine, Hunde und Katzen
Active substance:
  • Bromhexine hydrochloride
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Bromhexine hydrochloride
    3.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        2
        day
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05CB02
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 14143
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/05/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/05/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."